Synthesis method of 6-bromophthalazine
A synthetic method and phthalazine technology, which are applied in the field of synthesis of 6-bromophthalazine, can solve the problems of harsh reaction conditions, low reaction yield, unsuitable amplification, etc., and achieve mild reaction conditions, high yield, and improved yield Effect
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2020-11-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of synthesis of organic chemical intermediates, in particular to a synthesis method of 6-bromophthalazine. Background technique
[0002] 6-Bromophthalazine is a heterocyclic compound of phthalazines, which is an extremely important class of pharmaceutical intermediates with broad application prospects. The intermediate and its derivatives are used to construct many pharmaceutical active molecules. Such as the preparation of protein kinase inhibitors for the treatment of proliferative diseases, Eph receptor regulators for the treatment of nervous disorders, PI3 kinase inhibitors for the treatment of cancer, etc.
[0003] At present, the synthetic route of synthetic 6-bromophthalazine mainly contains two kinds of methods:
[0004] 1. Preparation with 4-bromophthalic acid as raw material
[0005]
[0006] This method is based on 4-bromophthalic acid as raw material, through three steps: 1) sodium borohydr...
Examples
Embodiment 1
[0037]
[0038] 4-Bromo-1,2-xylene (200g, 1.08mol, 1.0eq), NBS (500g, 2.81mol, 2.6eq) and AIBN (19.7g, 0.12mol, 0.11eq) were added to 2L of tetrachloride In carbon, the temperature was raised to reflux, reacted under this condition for 3 hours, cooled to room temperature, filtered, and the filtrate was spin-dried and then slurried with 400 mL of petroleum ether, filtered, and the solvent was removed under reduced pressure to obtain compound III (297 g, yield 80.1%);
Embodiment 2
[0040]
[0041] Compound III (280g, 0.82mol, 1.0eq) and tert-butyl hydrazinodicarboxylate (189.7 g, 0.82mol, 1.0eq) were dissolved in 2.8L of toluene, and a phase transfer catalyst TEAB (5.8g, 0.04 mol, 0.05eq) and 1.4L of 50% sodium hydroxide aqueous solution, then heated up to 100°C, reacted for 10 hours, after the reaction was completed, lowered to room temperature, separated, washed the organic phase with water, washed with saturated saline and dried, and then spin-dried , adding 500mL of methyl tert-butyl ether to the crude product, beating for 0.5 hours, filtering and drying to obtain compound IV (310g, yield 91.8%).
Embodiment 3
[0043]
[0044] Compound IV (300g, 0.73mol, 0.0eq) was dissolved in 1.5L of ethyl acetate, the temperature was lowered to 0°C, the temperature was controlled at 0-5°C, and 1.5L of ethyl acetate / HCl solution (4M) was added dropwise thereto , after the dropwise addition was completed, it was slowly raised to room temperature, reacted for 2 hours, and was filtered to obtain compound V (198 g, yield 95.4%).